Dr. Vijay Sankaran, a physician-scientist who investigates the molecular underpinnings of pediatric genetic blood disorders, has been awarded the third annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today.
It has come to our attention that many junior faculty members in our community are not familiar with other investigators in Harvard research labs who might serve as potential collaborators on this project. If this is the conundrum you face, please send us (maureen_herrmann@harvard.edu) a brief (no more than one page) explanation of your interest,...
The Harvard Department of Stem Cell and Regenerative Biology (HSCRB) invites applications for Pilot Grant funding for 2018 under the NIH-funded P01 grant “Dissecting the establishment and regulation of human pluripotency” (PI Alexander Meissner). The purpose of this funding program is to provide resources for proof-of-concept studies. These pilot grants are intended to increase our understanding of the basic biology of human pluripotent cells and their utility for translational applications.
HSCRB may fund up to 2 pilot grants in this round. Each project will be funded at a...
Associate Professor of Pathology, Harvard Medical School and Massachusetts General Hospital Neuro-Oncology Program, Dana-Farber/Harvard Cancer Center Institute Member, Broad Institute of MIT and Harvard
Mario Suva's research is focused on the biology of brain tumors, in particular diffuse high-grade gliomas in adults and children.
The Harvard Stem Cell Institute (HSCI) Blood Program invites applications for its 2017-2018 Pilot Grant cycle. The purpose of this funding program is to provide resources for projects in the field of blood stem cell biology with a basic, translational, or clinical research focus. HSCI is seeking to fund groundbreaking, innovative, high-impact research projects that could fundamentally enhance biomedical research in the field. Of particular interest to HSCI at this time is research...